Authors
Bob Bhayani, MBA, is founder and managing partner of DrDiasabilityQuotes.com and Axiom Financial Services. Bob regularly lectures hospitals and faculties on income protection and risk mitigation strategies. Bob specializes in working with residents and fellows, attending physicians, and private practices. Bob is a member of prestigious MDRT Top of the Table, Berkshire Inner Circle, and Chairman/Presidents Council.
Latest Article
Portsmouth: The Authentic New England Experience
Latest Article
IT'S OK TO CHEAT?
Advertisement
Advertisement
Trending on HCPLive
1
TRIUMPH-1: Retatrutide Substantially Lowers Weight, BMI in Patients With Obesity or Overweight
2
Survodutide Shows Fat Mass Loss, Liver Fat Reductions in Patients With Obesity Without T2D
3
What Comes Next for Berobenatide? VESPER-3 and Phase 3 Expectations, With John Buse, MD, PhD
4
TRANSCEND-T2D-1: Retatrutide Demonstrates Superior Weight Loss and A1c Results Versus Placebo
5

